Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Adherium Ltd. ( (AU:ADR) ) has issued an announcement.
Adherium Limited has issued 554,114,211 fully paid ordinary shares without a prospectus or disclosure document under the Corporations Act and has lodged a cleansing notice so these shares can be traded on the ASX without further disclosure. The company confirmed it is up to date with its financial reporting and continuous disclosure obligations and stated there is no excluded information requiring disclosure, signalling compliance with regulatory requirements as it expands its capital base.
The most recent analyst rating on (AU:ADR) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Adherium Ltd. stock, see the AU:ADR Stock Forecast page.
More about Adherium Ltd.
Adherium Limited is an Australian digital health company and global leader in connected respiratory medical devices. Its core Hailie® platform enables clinicians, healthcare providers and patients to remotely monitor respiratory medication usage and adherence, integrating data via mobile and desktop apps, SDKs, APIs and a proprietary range of connected sensors to support better management and understanding of chronic respiratory disease.
Technical Sentiment Signal: Sell
Current Market Cap: A$15.07M
For detailed information about ADR stock, go to TipRanks’ Stock Analysis page.